Cargando…

Quantification of Liver Fat Content after Radiofrequency Ablation for Liver Cancer: Correlation with Hepatic Perfusion Disorders

Purpose: To quantitatively investigate the correlation between liver fat content and hepatic perfusion disorders (HPD) after radiofrequency ablation (RFA) for liver cancer using magnetic resonance imaging (MRI)-determined proton density fat fraction (PDFF). Materials and methods: A total of 150 live...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Li-Shan, Li, Quan-Xi, Luo, Xiao-Wen, Tang, Hui-Jun, Tang, You-Jie, Tang, Wen-Jie, Guo, Ruo-Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625447/
https://www.ncbi.nlm.nih.gov/pubmed/34829484
http://dx.doi.org/10.3390/diagnostics11112137
_version_ 1784606423902060544
author Shen, Li-Shan
Li, Quan-Xi
Luo, Xiao-Wen
Tang, Hui-Jun
Tang, You-Jie
Tang, Wen-Jie
Guo, Ruo-Mi
author_facet Shen, Li-Shan
Li, Quan-Xi
Luo, Xiao-Wen
Tang, Hui-Jun
Tang, You-Jie
Tang, Wen-Jie
Guo, Ruo-Mi
author_sort Shen, Li-Shan
collection PubMed
description Purpose: To quantitatively investigate the correlation between liver fat content and hepatic perfusion disorders (HPD) after radiofrequency ablation (RFA) for liver cancer using magnetic resonance imaging (MRI)-determined proton density fat fraction (PDFF). Materials and methods: A total of 150 liver cancer patients underwent liver MRI examination within one month after RFA and at four months after RFA. According to the liver fat content, they were divided into non-, mild, moderate, and severe fatty liver groups. The liver fat content and hepatic perfusion disorders were determined using PDFF images and dynamic contrast-enhanced MRI images. The relationship between the liver fat content and HPD was investigated. Results: At the first postoperative MRI examination, the proportion of patients in the nonfatty liver group with hyperperfused foci (11.11%) was significantly lower than that in the mild (30.00%), moderate (42.86%), and severe fatty liver (56.67%) groups (p < 0.05), whereas the proportions of patients with hypoperfused foci (6.67%, 7.5%, 5.71%, and 6.67%, respectively) were not significantly different among the four groups (p > 0.05). In the nonfatty liver group, the liver fat content was not correlated with hyperperfusion abnormalities or hypoperfusion abnormalities. By contrast, in the three fatty liver groups, the liver fat content was correlated with hyperperfusion abnormalities but was not correlated with hypoperfusion abnormalities. At the second postoperative MRI examination, six patients in the nonfatty liver group were diagnosed with fatty liver, including two patients with newly developed hyperperfusion abnormalities and one patient whose hypoperfusion abnormality remained the same as it was in the first postoperative MRI examination. Conclusion: There was a high correlation between the liver fat content and hyperperfusion abnormalities after RFA for liver cancer. The higher the liver fat content was, the higher the was risk of hyperperfusion abnormalities. However, there was little correlation between liver fat content and hypoperfusion abnormalities, and the increase in postoperative liver fat content did not induce or alter the presence of hypoperfused foci.
format Online
Article
Text
id pubmed-8625447
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86254472021-11-27 Quantification of Liver Fat Content after Radiofrequency Ablation for Liver Cancer: Correlation with Hepatic Perfusion Disorders Shen, Li-Shan Li, Quan-Xi Luo, Xiao-Wen Tang, Hui-Jun Tang, You-Jie Tang, Wen-Jie Guo, Ruo-Mi Diagnostics (Basel) Article Purpose: To quantitatively investigate the correlation between liver fat content and hepatic perfusion disorders (HPD) after radiofrequency ablation (RFA) for liver cancer using magnetic resonance imaging (MRI)-determined proton density fat fraction (PDFF). Materials and methods: A total of 150 liver cancer patients underwent liver MRI examination within one month after RFA and at four months after RFA. According to the liver fat content, they were divided into non-, mild, moderate, and severe fatty liver groups. The liver fat content and hepatic perfusion disorders were determined using PDFF images and dynamic contrast-enhanced MRI images. The relationship between the liver fat content and HPD was investigated. Results: At the first postoperative MRI examination, the proportion of patients in the nonfatty liver group with hyperperfused foci (11.11%) was significantly lower than that in the mild (30.00%), moderate (42.86%), and severe fatty liver (56.67%) groups (p < 0.05), whereas the proportions of patients with hypoperfused foci (6.67%, 7.5%, 5.71%, and 6.67%, respectively) were not significantly different among the four groups (p > 0.05). In the nonfatty liver group, the liver fat content was not correlated with hyperperfusion abnormalities or hypoperfusion abnormalities. By contrast, in the three fatty liver groups, the liver fat content was correlated with hyperperfusion abnormalities but was not correlated with hypoperfusion abnormalities. At the second postoperative MRI examination, six patients in the nonfatty liver group were diagnosed with fatty liver, including two patients with newly developed hyperperfusion abnormalities and one patient whose hypoperfusion abnormality remained the same as it was in the first postoperative MRI examination. Conclusion: There was a high correlation between the liver fat content and hyperperfusion abnormalities after RFA for liver cancer. The higher the liver fat content was, the higher the was risk of hyperperfusion abnormalities. However, there was little correlation between liver fat content and hypoperfusion abnormalities, and the increase in postoperative liver fat content did not induce or alter the presence of hypoperfused foci. MDPI 2021-11-18 /pmc/articles/PMC8625447/ /pubmed/34829484 http://dx.doi.org/10.3390/diagnostics11112137 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Shen, Li-Shan
Li, Quan-Xi
Luo, Xiao-Wen
Tang, Hui-Jun
Tang, You-Jie
Tang, Wen-Jie
Guo, Ruo-Mi
Quantification of Liver Fat Content after Radiofrequency Ablation for Liver Cancer: Correlation with Hepatic Perfusion Disorders
title Quantification of Liver Fat Content after Radiofrequency Ablation for Liver Cancer: Correlation with Hepatic Perfusion Disorders
title_full Quantification of Liver Fat Content after Radiofrequency Ablation for Liver Cancer: Correlation with Hepatic Perfusion Disorders
title_fullStr Quantification of Liver Fat Content after Radiofrequency Ablation for Liver Cancer: Correlation with Hepatic Perfusion Disorders
title_full_unstemmed Quantification of Liver Fat Content after Radiofrequency Ablation for Liver Cancer: Correlation with Hepatic Perfusion Disorders
title_short Quantification of Liver Fat Content after Radiofrequency Ablation for Liver Cancer: Correlation with Hepatic Perfusion Disorders
title_sort quantification of liver fat content after radiofrequency ablation for liver cancer: correlation with hepatic perfusion disorders
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625447/
https://www.ncbi.nlm.nih.gov/pubmed/34829484
http://dx.doi.org/10.3390/diagnostics11112137
work_keys_str_mv AT shenlishan quantificationofliverfatcontentafterradiofrequencyablationforlivercancercorrelationwithhepaticperfusiondisorders
AT liquanxi quantificationofliverfatcontentafterradiofrequencyablationforlivercancercorrelationwithhepaticperfusiondisorders
AT luoxiaowen quantificationofliverfatcontentafterradiofrequencyablationforlivercancercorrelationwithhepaticperfusiondisorders
AT tanghuijun quantificationofliverfatcontentafterradiofrequencyablationforlivercancercorrelationwithhepaticperfusiondisorders
AT tangyoujie quantificationofliverfatcontentafterradiofrequencyablationforlivercancercorrelationwithhepaticperfusiondisorders
AT tangwenjie quantificationofliverfatcontentafterradiofrequencyablationforlivercancercorrelationwithhepaticperfusiondisorders
AT guoruomi quantificationofliverfatcontentafterradiofrequencyablationforlivercancercorrelationwithhepaticperfusiondisorders